BioPharma Resources

Drug Trial Radar · NCT07184931

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

A Multicenter, Multinational, Randomized, Double-blind, Placebo-controlled Phase 3, Induction Study to Evaluate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

Last checked: Nov 19, 2026Latest source record: Oct 21, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 980 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

980

Planned (sponsor's estimate)

Start

Oct 1, 2025

Primary completion

May 14, 2029

Study completion May 14, 2029

Sponsor

Lead sponsor
SanofiSanofi (SNY)
Sponsor type
Industry
Collaborators
Teva Branded Pharmaceutical Products R&D LLC
First posted
Sep 22, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 16 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a multinational, multicenter, randomized, double-blind, placebo-controlled, Phase 3 induction study, comprised of 3 sub-studies, to evaluate the efficacy and safety of duvakitug in participants with moderately to severely active CD. Study details include: The study duration may be up to 35 weeks with: * Up to 5-week Screening Period. * 12-week Sub-Study 1 (Single Arm Open-Label Feeder Induction) or Sub-Study 2 (Pivotal Induction). * 12-week Sub-Study 3 (Extended Induction for non-responders). * 6 weeks (45 days) follow-up period for participants who do not enroll into the Pivotal Maintenance Study (EFC18327). The treatment duration will be up to 12 weeks in each sub-study. The number of scheduled study visits for participants who continue to the Pivotal Maintenance Study (EFC18327) will be up to 8 (Sub-Study 1 and Sub-Study 2) and up to 15 for participants who enroll in Sub-Study 3.

Conditions

  • Crohn's Disease

Interventions

  • DuvakitugDrug

    Pharmaceutical form:Injection solution Route of administration:SC injection

  • PlaceboDrug

    Pharmaceutical form:Injection solution Route of administration:SC injection

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Sub-Study 2: Co-primary endpoints US/FDA: Proportion of participants achieving clinical remission per Crohn's Disease Activity Index (CDAI) at Week 12Time frame: Week 12
  2. Sub-Study 2: Co-primary endpoints US/FDA: Proportion of participants achieving endoscopic response (Simple Endoscopic Score for Crohn's Disease [SES-CD]) at Week 12Time frame: Week 12
  3. Sub-Study 2: Co-primary endpoints EU/EMA: Proportion of participants achieving clinical remission per 2-item patient-reported outcome (PRO-2) at Week 12Time frame: Week 12
  4. Sub-Study 2: Co-primary endpoints EU/EMA: Proportion of participants achieving endoscopic response (SES-CD) at Week 12Time frame: Week 12

Locations

461 sites in 36 countries. Site status is shown where the registry gives one.

  • Onyx Clinical Research - Site Number:8400021

    Peoria, Arizona · Recruiting

  • One of a Kind Clinical Research Center AZ, LLC-Site Number: 8400061

    Scottsdale, Arizona · Recruiting

  • Scottsdale Clinical Trials-Site Number: 8400145

    Scottsdale, Arizona · Recruiting

  • Del Sol Research Management, LLC-Site Number: 8400012

    Tucson, Arizona · Recruiting

  • Preferred Research Partners-Site Number: 8400018

    Little Rock, Arkansas · Recruiting

  • Alliance Research Institute-Site Number: 8400008

    Canoga Park, California · Recruiting

  • Southern California GI & Liver Centers-Site Number: 8400062

    Coronado, California · Recruiting

  • Gastroenterology and Liver Institute - Escondido-Site Number: 8400146

    Escondido, California · Recruiting

  • GMC Clinical Research, LLC-Site Number: 8400113

    Folsom, California · Recruiting

  • Om Research, LLC - Lancaster-Site Number: 8400148

    Lancaster, California · Recruiting

  • TLC Clinical Research Inc.-Site Number: 8400030

    Los Angeles, California · Recruiting

  • GastroIntestinal Bioscience - Los Angeles-Site Number: 8400019

    Los Angeles, California · Recruiting

  • United Medical Doctors CA-Site Number: 8400044

    Murrieta, California · Recruiting

  • Om Research, LLC - Oxnard-Site Number: 8400150

    Oxnard, California · Recruiting

  • Prospective Research Innovations Inc.-Site Number: 8400017

    Rancho Cucamonga, California · Recruiting

  • UC Davis Health System-Site Number: 8400071

    Sacramento, California · Recruiting

  • Clinical Applications Laboratories Inc-Site Number: 8400056

    San Diego, California · Recruiting

  • Medical Associates Research Group-Site Number:8400063

    San Diego, California · Recruiting

  • Valiance Clinical Research - Tarzana-Site Number: 8400023

    Tarzana, California · Recruiting

  • Clinical Trials Management Services-Site Number: 8400047

    Thousand Oaks, California · Recruiting

  • Amicis Research Center - Valencia-Site Number: 8400064

    Valencia, California · Recruiting

  • Om Research, LLC - Victorville-Site Number: 8400022

    Victorville, California · Recruiting

  • UCHealth Digestive Health Center - Anschutz Medical Campus-Site Number: 8400085

    Aurora, Colorado · Recruiting

  • Peak Gastroenterology Associates - Colorado Springs-Site Number: 8400039

    Colorado Springs, Colorado · Recruiting

  • Gastroenterology of the Rockies - Denver-Site Number: 8400122

    Denver, Colorado · Recruiting

  • Yale University Digestive Disease-Site Number: 8400108

    New Haven, Connecticut · Recruiting

  • Novum Research, LLC-Site Number: 8400003

    Clermont, Florida · Recruiting

  • Sarkis Clinical Trials - Gainesville-Site Number: 8400048

    Gainesville, Florida · Recruiting

  • Clinical Research of Osceola-Site Number: 8400013

    Kissimmee, Florida · Recruiting

  • Columbus Clinical Services LLc-Site Number: 8400038

    Miami, Florida · Recruiting

  • Regis Clinical Research, LLC-Site Number: 8400041

    Miami, Florida · Recruiting

  • Sylvester Comprehensive Cancer Center - A University of Miami Hospital and Clinics Facility - Miami-Site Number: 8400111

    Miami, Florida · Recruiting

  • Medical Professional Clinical Research Center-Site Number: 8400119

    Miami, Florida · Recruiting

  • Bioresearch Partner-Kendale Lakes-Site Number: 8400053

    Miami, Florida · Recruiting

  • Paradisus Med Research-Site Number: 8400036

    Miami, Florida · Recruiting

  • Correa Research Center-Site Number: 8400010

    Miami, Florida · Recruiting

  • AdventHealth Orlando-Site Number: 8400070

    Orlando, Florida · Recruiting

  • Orlando Health, Inc.-Site Number: 8400084

    Orlando, Florida · Recruiting

  • Tropical Clinical Trials-Site Number: 8400082

    Palmetto Bay, Florida · Recruiting

  • Precision Clinical Research - Sunrise-Site Number: 8400059

    Sunrise, Florida · Recruiting

Showing 40 of 461 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.